Transactions disclosed by company insiders to the SEC on Form 4, most recent first.
| Insider | Role | Date | Shares | Value |
|---|---|---|---|---|
| Lillie James Woodruff | Chief Scientific Officer | 2026-08-03 | 22,082 | $276,908 |
| Cox Troy | Insider | 2026-07-28 | 15,620 | $148,702 |
Position changes disclosed in SEC Form 13F filings. These report a quarterly snapshot, not exact trade dates.
| Fund | Change | Quarter |
|---|---|---|
| NOVO HOLDINGS A/S | NOVO HOLDINGS A/S increased this position by 76% ($74,949,025 -> $132,128,532). | 2026-06-30 |
| FCPM III SERVICES B.V. | FCPM III SERVICES B.V. increased this position by 76% ($65,592,712 -> $115,634,176). | 2026-06-30 |
| Paradigm Biocapital Advisors LP | Paradigm Biocapital Advisors LP opened a new position worth $24,580,936. | 2026-06-30 |
| Sanofi | Sanofi increased this position by 104% ($16,020,000 -> $32,687,549). | 2026-06-30 |
| GOLDMAN SACHS GROUP INC | GOLDMAN SACHS GROUP INC increased this position by 68% ($23,041,717 -> $38,799,237). | 2026-06-30 |
| Nan Fung Group Holdings Ltd | Nan Fung Group Holdings Ltd increased this position by 76% ($19,745,573 -> $34,809,708). | 2026-06-30 |
| Capital World Investors | Capital World Investors opened a new position worth $14,899,763. | 2026-06-30 |
| 5AM Venture Management, LLC | 5AM Venture Management, LLC increased this position by 76% ($19,313,724 -> $34,048,394). | 2026-06-30 |
Largest reported positions as of 2026-06-30.
| Fund | Value | Shares |
|---|---|---|
| NOVO HOLDINGS A/S | $132,128,532 | 3,686,622 |
| FCPM III SERVICES B.V. | $115,634,176 | 3,226,400 |
| GOLDMAN SACHS GROUP INC | $38,799,237 | 1,082,568 |
| Nan Fung Group Holdings Ltd | $34,809,708 | 971,253 |
| 5AM Venture Management, LLC | $34,048,394 | 950,011 |
| Sanofi | $32,687,549 | 912,041 |
| VANGUARD CAPITAL MANAGEMENT LLC | $28,103,936 | 784,150 |
| Blue Owl Capital Holdings LP | $26,160,655 | 729,929 |
| Paradigm Biocapital Advisors LP | $24,580,936 | 685,852 |
| Pivotal bioVenture Partners Investment Advisor LLC | $21,914,225 | 611,446 |
Data compiled from public SEC filings. This is informational reporting, not investment advice.
This page tracks Sanofi’s institutional portfolio activity as disclosed in its quarterly Form 13F filings with the SEC. Rather than a one-off news snapshot, think of it as a running ledger — new positions, exits, and size changes get logged here every quarter so you can see how the company’s biotech and pharma stakes shift … Read more
Blue Owl Capital Holdings LP’s portfolio moves, tracked quarter by quarter, based on its SEC Form 13F filings. These filings offer a quarterly snapshot of U.S. equity holdings for institutional investment managers, revealing what a fund added, trimmed, or exited entirely. They do not show exact trade dates or the reasoning behind a move, but … Read more